Ethanol extract of Innotus obliquus (Chaga mushroom) induces G1 cell cycle arrest in HT-29 human colon cancer cells
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
BACKGROUND/OBJECTIVES: Inonotus obliquus (I. obliquus, Chaga mushroom) has long been used as a folk medicine to treatcancer. In the present study, we examined whether or not ethanol extract of I. obliquus (EEIO) inhibits cell cycle progressionin HT-29 human colon cancer cells, in addition to its mechanism of action. MATERIALS/METHODS: To examine the effects of Inonotus obliquus on the cell cycle progression and the molecular mechanismin colon cancer cells, HT-29 human colon cancer cells were cultured in the presence of 2.5 - 10 μg/mL of EEIO, and analyzedthe cell cycle arrest by flow cytometry and the cell cycle controlling protein expression by Western blotting. RESULTS: Treatment cells with 2.5 - 10 μg/mL of EEIO reduced viable HT-29 cell numbers and DNA synthesis, increased thepercentage of cells in G1 phase, decreased protein expression of CDK2, CDK4, and cyclin D1, increased expression of p21,p27, and p53, and inhibited phosphorylation of Rb and E2F1 expression. Among I. obliquus fractions, fraction 2 (fractionatedby dichloromethane from EEIO) showed the same effect as EEIO treatment on cell proliferation and cell cycle-related proteinlevels. CONCLUSIONS: These results demonstrate that fraction 2 is the major fraction that induces G1 arrest and inhibits cell proliferation,suggesting I. obliquus could be used as a natural anti-cancer ingredient in the food and/or pharmaceutical industry.
Abstract
BACKGROUND/OBJECTIVES: Inonotus obliquus (I. obliquus, Chaga mushroom) has long been used as a folk medicine to treat cancer. In the present study, we examined whether or not ethanol extract of I. obliquus (EEIO) inhibits cell cycle progressionin HT-29 human colon cancer cells, in addition to its mechanism of action. MATERIALS/METHODS: To examine the effects of Inonotus obliquus on the cell cycle progression and the molecular mechanism in colon cancer cells, HT-29 human colon cancer cells were cultured in the presence of 2.5 - 10 μg/mL of EEIO, and analyzedthe cell cycle arrest by flow cytometry and the cell cycle controlling protein expression by Western blotting. RESULTS: Treatment cells with 2.5 - 10 μg/mL of EEIO reduced viable HT-29 cell numbers and DNA synthesis, increased the percentage of cells in G1 phase, decreased protein expression of CDK2, CDK4, and cyclin D1, increased expression of p21, p27, and p53, and inhibited phosphorylation of Rb and E2F1 expression. Among I. obliquus fractions, fraction 2 (fractionated by dichloromethane from EEIO) showed the same effect as EEIO treatment on cell proliferation and cell cycle-related protein levels. CONCLUSIONS: These results demonstrate that fraction 2 is the major fraction that induces G1 arrest and inhibits cell proliferation,suggesting I. obliquus could be used as a natural anti-cancer ingredient in the food and/or pharmaceutical industry.
참고문헌 (40)
- Taji S, "Three new lanostane triterpenoids from Inonotus obliquus", Helv Chim Acta, 90, pp.2047~2057 (2007)
- Saar M, "Fungi in khanty folk medicine", J Ethnopharmacol, 31, pp.175~179 (1991)
- Zhao F, "Studies on anti-mutation active constituents of the Fuscoporia oblique", J Med Sci Yanbian Univ, 27, pp.250~252 (2004)
- Chen, Hui, "Optimization of Hydroxyl Radical Scavenging Activity of Exopolysaccharides from Inonotus obliquus in Submerged Fermentation Using Response Surface Methodology", Journal of Microbiology and Biotechnology, 20(4), pp.835~843 (2010), 한국미생물·생명공학회
- Choi SY, "Anti-inflammatory effects of Inonotus obliquus in colitis induced by dextran sodium sulfate", J Biomed Biotechnol, 2010, pp.943516~ (2010)
- Kahlos K, "Antitumor activity of some compounds and fractions from an n-hexane extract of Inonotus obliquus in vitro", Acta Pharm Fennica, 96, pp.33~40 (1987)
- Ichimura T, "Inhibition of HIV-1 protease by water-soluble lignin-like substance from an edible mushroom, Fuscoporia obliqua", Biosci Biotechnol Biochem, 62, pp.575~577 (1998)
- Nakata T, "Structure determination of inonotsuoxides A and B and in vivo anti-tumor promoting activity of inotodiol from the sclerotia of Inonotus obliquus", Bioorg Med Chem, 15, pp.257~264 (2007)
- Shibnev VA, "Antiviral activity of Inonotus obliquus fungus extract towards infection caused by hepatitis C virus in cell cultures", Bull Exp Biol Med, 151, pp.612~614 (2011)
- Song FQ, "Progress on understanding the anticancer mechanisms of medicinal mushroom:inonotus obliquus", Asian Pac J Cancer Prev, 14, pp.1571~1578 (2013)
- Lee SH, "Antitumor activity of water extract of a mushroom, Inonotus obliquus, against HT-29 human colon cancer cells", Phytother Res, 23, pp.1784~1789 (2009)
- Lee IK, "New antioxidant polyphenols from the medicinal mushroom Inonotus obliquus", Bioorg Med Chem Lett, 17, pp.6678~6681 (2007)
- Park YM, "In vivo and in vitro anti-inflammatory and anti-nociceptive effects of the methanol extract of Inonotus obliquus", J Ethnopharmacol, 101, pp.120~128 (2005)
- Nakajima Y, "Antioxidant small phenolic ingredients in Inonotus obliquus (persoon) Pilat (Chaga)", Chem Pharm Bull (Tokyo), 55, pp.1222~1226 (2007)
- Youn MJ, "Chaga mushroom (Inonotus obliquus)induces G0", G1 arrest and apoptosis in human hepatoma HepG2cells, 2008, pp.14, 511~517
- Hyun KW, "Isolation and characterization of a novel platelet aggregation inhibitory peptide from the medicinal mushroom, Inonotus obliquus", Peptides, 27, pp.1173~1178 (2006)
- Cui Y, "Antioxidant effect of Inonotus obliquus", J Ethnopharmacol, 96, pp.79~85 (2005)
- Ma L, "Anti-inflammatory and anticancer activities of extracts and compounds from the mushroom Inonotus obliquus", Food Chem, 139, pp.503~508 (2013)
- Senderowicz AM, "Novel direct and indirect cyclin-dependent kinase modulators for the prevention and treatment of human neoplasms", Cancer Chemother Pharmacol, 52(Suppl 1), pp.S61~S73 (2003)
- Swanton C, "Cell-cycle targeted therapies", Lancet Oncol, 5, pp.27~36 (2004)
- Sherr CJ, "Cancer cell cycles", Science, 274, pp.1672~1677 (1996)
- Johnson DG, "Cyclins and cell cycle checkpoints", Annu Rev Pharmacol Toxicol, 39, pp.295~312 (1999)
- Vermeulen K, "The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer", Cell Prolif, 36, pp.131~149 (2003)
- Hall M, "Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer", Adv Cancer Res, 68, pp.67~108 (1996)
- Kim EJ, "Trans-10,cis-12-conjugated linoleic acid inhibits Caco-2 colon cancer cell growth", Am J Physiol Gastrointest Liver Physiol, 283, pp.G357~G367 (2002)
- Cho HJ, "Trans-10,cis-12, not cis-9,trans-11, conjugated linoleic acid inhibits G1-S progression in HT-29 human colon cancer cells", J Nutr, 136, pp.893~898 (2006)
- Cho HJ, "Conjugated linoleic acid inhibits cell proliferation and ErbB3signaling in HT-29 human colon cell line", Am J Physiol Gastrointest Liver Physiol, 284, pp.G996~G1005 (2003)
- Kim EJ, "Apoptosis of DU145 human prostate cancer cells induced by dehydrocostus lactone isolated from the root of Saussurea lappa", Food Chem Toxicol, 46, pp.3651~3658 (2008)
- Handa N, "Four new lanostane-type triterpenoids from Inonotus obliquus", Phytochem Lett, 5, pp.480~485 (2012)
- Song Y, "Identification of Inonotus obliquus and analysis of antioxidation and antitumor activities of polysaccharides", Curr Microbiol, 57, pp.454~462 (2008)
- Sun Y, "In vitro antitumor activity and structure characterization of ethanol extracts from wild and cultivated Chaga medicinal mushroom, Inonotus obliquus (Pers.:Fr.) Pilát (Aphyllophoromycetideae)", Int J Med Mushrooms, 13, pp.121~130 (2011)
- Xiong Y, "p21is a universal inhibitor of cyclin kinases", Nature, 366, pp.701~704 (1993)
- Gartel AL, "Transcriptional regulation of the p21(WAF1", CIP1) gene, 1999, pp.246, 280~289
- Chu IM, "The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy", Nat Rev Cancer, 8, pp.253~267 (2008)
- Wu CL, "In vivo association of E2F and DP family proteins", Mol Cell Biol, 15, pp.2536~2546 (1995)
- Das SK, "Fucoxanthin induces cell cycle arrest at G0", G1 phase in human colon carcinoma cells through up-regulation of p21WAF1, Biochim Biophys Acta, pp.2005, 1726[DOI]
- Bartkova J, "Cell-cycle regulatory proteins in human wound healing", Arch Oral Biol, 48, pp.125~132 (2003)
- Korenjak M, "E2F-Rb complexes regulating transcription of genes important for differentiation and development", Curr Opin Genet Dev, 15, pp.520~527 (2005)
- obliquus by induction of apoptosis in melanoma B16-F10 cells, "J Ethnopharmacol", 2009, 221~228
- 정미자, "Anticancer activity of subfractions containing pure compounds of Chaga mushroom (Inonotus obliquus) extract in human cancer cells and in Balbc", c mice bearing Sarcoma-180 cells, 2010, pp.4(3), 177~182[DOI]